NEW YORK (GenomeWeb) – The field of personalized medicine has been suffering from a credibility problem. More than a decade after the completion of the Human Genome Project, some are disappointed at the limited number of new life-extending treatments that have resulted from the nearly $3 billion effort. The stewards of the HGP had overpromised what could be gleaned from the human biological blueprint, critics have said, wondering where all the cures are.
To read the full story....
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.